43 results on '"Gebo, Kelly A"'
Search Results
2. 2670. Sexual Health Evaluation Among People Tested for Mpox in an Urban Health System
3. 401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy
4. 2664. Patient Perspectives on Care Outcomes and Interactions with an Urban Emergency Department Health System for Mpox: A Quality Improvement Study
5. 2505. Using an Electronic Medical Record Alert to Screen Inpatient Encounters for People with Hepatitis C
6. Hospital Readmissions among Persons with HIV in the United States and Canada, 2005–2018: A Collaboration of Cohort Studies
7. Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients
8. Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample
9. Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine
10. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout
11. Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey
12. Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019 (COVID-19)
13. Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
14. Reply to Steele et al
15. A Growing Number of Men Who Have Sex With Men Aging With HIV (2021–2031): A Comparison of Two Microsimulation Models
16. Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial
17. Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015
18. 444. County-level COVID-19 Case Fatality Rate in Medicaid Expansion States Compared to Non-Expansion States
19. 48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic
20. Pediatric data from the All of Us research program: demonstration of pediatric obesity over time
21. Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020
22. The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities
23. 2520. Resource utilization in adolescents and young adults with HIV in the HIV Research Network
24. 2845. Oral Antibiotic Use and Risk of Colorectal Cancer in the UK, 1989–2012: A Matched Case–Control Study
25. End-Stage Renal Disease Among HIV-Infected Adults in North America
26. Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act
27. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010
28. Uptake and Virologic Outcomes of 1-Pill versus Multipill Antiretroviral Therapy Among Treatment-Naive Nonperinatally HIV-Infected Youth (2006–2014)
29. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America
30. Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection
31. Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults
32. Factors Associated With Retention Among Non–Perinatally HIV-Infected Youth in the HIV Research Network
33. Antiretroviral Medication Errors Remain High but Are Quickly Corrected Among Hospitalized HIV-Infected Adults
34. Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada
35. Racial and Sex Disparities in Life Expectancy Losses among HIV‐Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral Therapy
36. Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy–Experienced Patients with HIV Infection in North America
37. Lumbar Puncture in HIV‐Infected Patients with Syphilis and No Neurologic Symptoms
38. Rate of Comorbidities Not Related to HIV Infection or AIDS among HIV‐Infected Patients, by CD4 Cell Count and HAART Use Status
39. Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research Directions
40. Antiretroviral Therapy Is Associated with Reduced Serologic Failure Rates for Syphilis among HIV‐Infected Patients
41. Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
42. Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy
43. Pseudo‐outbreak ofMycobacterium fortuitumon a Human Immunodeficiency Virus Ward: Transient Respiratory Tract Colonization from a Contaminated Ice Machine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.